Frontline plc grants 276,895 synthetic options to management and employees, vesting over three years. The options have a five-year term and an exercise price of USD 36.8, adjusted for dividends. The CEO and CFO's options have a cap on maximum annual gain equal to two times their base salary.
Sign in to access complete coverage, AI analysis, and related companies.
Sign In to Continue